Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01512264 · ClinicalTrials.gov registry record · NA
Post-Stroke Aphasia and Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment Study
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT01512264 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 28 participants.
The verdict
NCT01512264, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
In this study the investigators will examine the efficacy of navigated excitatory repetitive transcranial magnetic stimulation (nerTMS) for the treatment of post stroke aphasia. The investigators expect that this new types of rehabilitation (nerTMS) will help patients with aphasia return to their lives as they were prior to the stroke.
Interventions
- DEVICE Magstim SuperRapid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2012-01 |
| Est. Completion | 2018-07-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01512264
The ClinicalTrials.gov registry entry for NCT01512264 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magstim SuperRapid is the first listed.
NCT01512264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01512264 about?
NCT01512264 is a clinical study titled "Post-Stroke Aphasia and Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment Study". In this study the investigators will examine the efficacy of navigated excitatory repetitive transcranial magnetic stimulation (nerTMS) for the treatment of post stroke aphasia. The investigators expect that this new types of rehabilitation (nerTMS) will help patients with aphasia return to their li...
What is the current status of trial NCT01512264?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2012-01. Estimated completion is 2018-07-20.
What interventions are being tested in trial NCT01512264?
The interventions under investigation include: Magstim SuperRapid (DEVICE).
Who is sponsoring clinical trial NCT01512264?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.